tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2696 Stock Latest News

Shanghai Henlius Biotech’s HLX11 Receives FDA Approval for Breast Cancer Treatment
Company AnnouncementsShanghai Henlius Biotech’s HLX11 Receives FDA Approval for Breast Cancer Treatment
3d ago
2696
Shanghai Henlius Biotech Secures FDA Orphan-drug Designation for HLX43
PremiumCompany Announcements
Shanghai Henlius Biotech Secures FDA Orphan-drug Designation for HLX43
1M ago
2696
Shanghai Henlius Biotech’s HANSIZHUANG Shows Promising Results in Gastric Cancer Treatment
PremiumCompany Announcements
Shanghai Henlius Biotech’s HANSIZHUANG Shows Promising Results in Gastric Cancer Treatment
1M ago
2696
Shanghai Henlius Biotech Advances in Oncology with New Clinical Trial Approval
PremiumCompany Announcements
Shanghai Henlius Biotech Advances in Oncology with New Clinical Trial Approval
2M ago
2696
Shanghai Henlius Biotech’s HLX13 Receives FDA Approval for Clinical Trial
PremiumCompany Announcements
Shanghai Henlius Biotech’s HLX13 Receives FDA Approval for Clinical Trial
2M ago
2696
Shanghai Henlius Initiates Global Trial for Cancer Treatment Biosimilar
PremiumCompany AnnouncementsShanghai Henlius Initiates Global Trial for Cancer Treatment Biosimilar
2M ago
2696
Shanghai Henlius Biotech Gains EU Approval for Osteoporosis Treatments
Premium
Company Announcements
Shanghai Henlius Biotech Gains EU Approval for Osteoporosis Treatments
2M ago
2696
Shanghai Henlius Biotech Advances HLX43 Clinical Trials for Lung Cancer
Premium
Company Announcements
Shanghai Henlius Biotech Advances HLX43 Clinical Trials for Lung Cancer
2M ago
2696
Shanghai Henlius Biotech’s HLX17 Receives FDA Approval for Clinical Trials
PremiumCompany Announcements
Shanghai Henlius Biotech’s HLX17 Receives FDA Approval for Clinical Trials
2M ago
2696
Shanghai Henlius Biotech Receives FDA Approval for Two Biosimilars
PremiumCompany Announcements
Shanghai Henlius Biotech Receives FDA Approval for Two Biosimilars
3M ago
2696
Shanghai Henlius Biotech Confirms Leadership Continuity with Board Re-appointments
PremiumCompany Announcements
Shanghai Henlius Biotech Confirms Leadership Continuity with Board Re-appointments
3M ago
2696
Shanghai Henlius Biotech Announces Board Composition and Roles
PremiumCompany Announcements
Shanghai Henlius Biotech Announces Board Composition and Roles
3M ago
2696
Shanghai Henlius Biotech Grants Options and RSUs to Boost Performance
PremiumCompany AnnouncementsShanghai Henlius Biotech Grants Options and RSUs to Boost Performance
3M ago
2696
Shanghai Henlius Biotech: Strong Financial Performance and Promising Product Pipeline Drive Buy Rating
Premium
Ratings
Shanghai Henlius Biotech: Strong Financial Performance and Promising Product Pipeline Drive Buy Rating
3M ago
Shanghai Henlius Biotech Reports Growth and Expands Global Reach in 2025
Premium
Company Announcements
Shanghai Henlius Biotech Reports Growth and Expands Global Reach in 2025
3M ago
2696
Shanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
PremiumCompany Announcements
Shanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
3M ago
2696
Shanghai Henlius Biotech Clarifies Member Register Closure Procedures
PremiumCompany Announcements
Shanghai Henlius Biotech Clarifies Member Register Closure Procedures
3M ago
2696
Shanghai Henlius Biotech’s New Drug Application for HLX04-O Accepted by NMPA
PremiumCompany Announcements
Shanghai Henlius Biotech’s New Drug Application for HLX04-O Accepted by NMPA
3M ago
2696
Shanghai Henlius Biotech Announces Extraordinary General Meeting for Key Resolutions
PremiumCompany Announcements
Shanghai Henlius Biotech Announces Extraordinary General Meeting for Key Resolutions
3M ago
2696
Shanghai Henlius Biotech Announces New Board Appointments
PremiumCompany AnnouncementsShanghai Henlius Biotech Announces New Board Appointments
3M ago
2696
Shanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
Premium
Company Announcements
Shanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
3M ago
2696
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
Premium
Company Announcements
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
3M ago
2696

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >